Plötz Frans B, Bouma Angelique B, van Wijk Joanna A E, Kneyber Martin C J, Bökenkamp Arend
Department of Pediatric Intensive Care, VU University Medical Center, P. O. Box 7057, 1007 MB, Amsterdam, The Netherlands.
Intensive Care Med. 2008 Sep;34(9):1713-7. doi: 10.1007/s00134-008-1176-7. Epub 2008 Jun 3.
The present study was undertaken to evaluate the practicability of the proposed pediatric RIFLE (pRIFLE) criteria in a patient population at risk for acute kidney injury (AKI) and to analyze the prevalence and association of AKI as defined by pRIFLE with mortality.
Retrospective, descriptive cohort study.
Single-center, 9-bed PICU facility.
Children with respiratory failure requiring mechanical ventilation for more than 4 days admitted between January 2002 and December 2006.
None.
Data of 103 patients were studied. Median age was 4.5 years (range 1 month-17 years). Six patients received renal replacement therapy. Seventeen patients (17%) died. Sixty patients (58%) developed AKI by pRIFLE. Mean time to attainment of the first RIFLE stratum was 1.9 +/- 1.6 days. By pRIFLE, 34 of the 60 patients fulfilled the maximum AKI criteria on the first day after admission based on the estimated creatinine clearance criterion. Patients with AKI according to the pRIFLE scoring system had five times higher mortality than patients without AKI (25 vs. 5%, P < 0.05).
We observed a high incidence of significant AKI in a PICU population at risk, which was associated with high mortality. Pediatric RIFLE criteria may guide in the early identification of patients at risk for AKI and in the initiation of therapy.
本研究旨在评估拟议的儿科RIFLE(pRIFLE)标准在急性肾损伤(AKI)风险患者群体中的实用性,并分析pRIFLE定义的AKI的患病率及其与死亡率的关联。
回顾性描述性队列研究。
单中心、拥有9张床位的儿科重症监护病房。
2002年1月至2006年12月期间因呼吸衰竭需要机械通气超过4天的儿童。
无。
对103例患者的数据进行了研究。中位年龄为4.5岁(范围1个月至17岁)。6例患者接受了肾脏替代治疗。17例患者(17%)死亡。60例患者(58%)根据pRIFLE标准发生了AKI。达到首个RIFLE分级的平均时间为1.9±1.6天。根据pRIFLE标准,60例患者中有34例在入院后第一天根据估算的肌酐清除率标准达到了最大AKI标准。根据pRIFLE评分系统诊断为AKI的患者死亡率是未发生AKI患者的5倍(25%对5%,P<0.05)。
我们观察到在有风险的儿科重症监护病房患者群体中,严重AKI的发生率很高,且与高死亡率相关。儿科RIFLE标准可能有助于早期识别有AKI风险的患者并启动治疗。